Skip to main content
. 2021 May 3;48(12):3886–3902. doi: 10.1007/s00259-021-05362-8

Fig. 4.

Fig. 4

The proportion of patients with a positive [18F]FDG-PET/CT during clinical remission in longitudinal studies. Per scan data or per patient data at baseline and during serial scans were obtained, if the disease activity during the scans was clearly defined. a Timing of follow-up scans and b the number of patients with a positive scan during clinical remission in each study